Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Current issues and future directions in treatment.

Chee-Kin Hui¹, George K K Lau

¹Center for the Study of Liver Diseases, The University of Hong Kong, SAR, China.

Seminars in Liver Disease

|May 5, 2006

Summary

Understanding host immune responses is key to improving chronic hepatitis B (CHB) treatment. Better insights can lead to therapies that achieve sustained viral suppression and disease remission.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Idiopathic multitudinous fundic gland polyposis: A new disease and a management dilemma.

JGH open : an open access journal of gastroenterology and hepatology·2021

Same author

Impact of metabolic risk factors on the severity and outcome of patients with alcohol-associated acute-on-chronic liver failure.

Liver international : official journal of the International Association for the Study of the Liver·2020

Same author

APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation.

Hepatology international·2019

Same author

How do we handle the anti-HBc positive patient? (in highly endemic settings).

Clinical liver disease·2019

Same author

APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment?

Hepatology international·2018

Same author

Recurrent Intestinal Obstruction in a Patient with Selective IgA Deficiency.

The Malaysian journal of medical sciences : MJMS·2017

Area of Science:

Hepatology
Immunology
Virology

Background:

Chronic hepatitis B (CHB) can lead to severe liver conditions like cirrhosis and cancer.
Host immune response to hepatitis B virus (HBV) antigens significantly influences CHB outcomes.
Sustained viral suppression below 10^4 to 10^5 copies/mL is linked to disease remission.

Purpose of the Study:

To explore the host immune characteristics associated with sustained disease remission in CHB.
To identify potential targets for improved CHB immunomodulatory therapies.

Main Methods:

Review of existing literature on CHB pathogenesis and treatment responses.
Analysis of host immune profiles in patients achieving sustained viral suppression.

Main Results:

Current therapies include immunomodulatory (interferon-alfa) and nucleos(t)ide treatments.
Nucleos(t)ide therapy offers viral suppression but risks resistance and long-term safety issues.
Limited understanding of host immunity hinders development of more effective therapies.

Conclusions:

Further research into host immune responses is crucial for advancing CHB treatment.
Identifying immune correlates of remission could pave the way for novel therapeutic strategies.
A deeper understanding may overcome limitations of current antiviral and immunomodulatory approaches.

Related Experiment Videos